Basic information
- Name:
Sodium salicylate
- CAS No.:
54-21-7
- Molecular Structure:

- Formula:
- C7H5NaO3
- Molecular Weight:
- 160.11
- Deleted CAS:
- 94413-51-1|18495-69-7
- Synonyms:
- Parbocyl-Rev;CLIN;Kerosal;Sodium 2-hydroxybenzoate;Sodium o-hydroxybenzoate;o-Hydroxybenzoic acid, sodium salt;Salsonin (TN);Enterosalil;Diuretin;Entrosalyl;Salicylic acid Na+;Aroall;Sodium salicylic acid;Salsonin;Nadisal;Magsalyl;Salisod;Benzoic acid, 2-hydroxy-, monosodium salt;Salicylic acid, sodium salt;Kerasalicyl;Alysine;Sodium salicylate (NaO3C7H5);Neo-Salicyl;Salicylic acid, monosodium salt;Benzoic acid,2-hydroxy-,compounds,monosodium salt;Sodium salicylate (JP14/USP);Monosodium salicylate;Glutosalyl;o-Hydroxybenzoic sodium salt;Salicylate, sodium;
- EINECS:
- 200-198-0
- Melting Point:
- 200 °C
- Boiling Point:
- 336.3 °C at 760 mmHg
- Flash Point:
- 144.5 °C
- Appearance:
- white crystals
- Hazard Symbols:
Xi,
Xn- Risk Codes:
- 22-41-36/37/38
- Safety Description:
- 26-36 Details
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers will soon
contact you!
*Required Fields
Consensus Reports
Specification
The Sodium salicylate, with the CAS registry number 54-21-7, is a kind of white powder. This is easily soluble in water(1:0.8,25℃) and glycerol while insoluble in ether, chloroform and benzene. Being stable chemically while incompatible with mineral acids and metallic salts, this chemical is light-sensitive.
The physical properties of this chemical are as follows: (1)ACD/LogP: 2.06; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.93; (4)ACD/LogD (pH 7.4): -1.09; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 3; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 2; (12)Polar Surface Area: 46.53; (13)Flash Point: 144.5 °C; (14)Enthalpy of Vaporization: 61.16 kJ/mol; (15)Boiling Point: 336.3 °C at 760 mmHg; (16)Vapour Pressure: 4.45E-05 mmHg at 25°C; (17)Exact Mass: 160.013639; (18)MonoIsotopic Mass: 160.013639; (19)Topological Polar Surface Area: 60.4; (20)Heavy Atom Count: 11; (21)Complexity: 138.
The production method of this chemical: Add salicylic acid and sodium bicarbonate into the distilled water with the temperature of 60℃, and then add EDTA and sodium hydrosulfite with defined amount; Next heat it to 85℃ and react for about half an hour; Lastly filter the qualified reaction liquid into the fluidized bed and then dry to 85℃ to get this product.
As to its usage, it is widely applied in many ways. It could be used in organic synthetic materials, antiseptic, the reagent testing the gastric acid in the free agents; It could also be used as the drug with the function of being antifebrile and anti-rheumatic. In addition, it is also a potential replacement for aspirin for people sensitive to it.
When you are dealing with this chemical, you should be much more cautious. For one thing, it is irritant to eyes, respiratory system and skin, which may also cause inflammation to the skin or other mucous membranes. For another thing, it is harmful which may cause damage to health and it may have risk of serious damage to eyes. Therefore, you should wear suitable protective clothing. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C1=CC=C(C(=C1)C(=O)[O-])O.[Na+]
(2)InChI: InChI=1S/C7H6O3.Na/c8-6-4-2-1-3-5(6)7(9)10;/h1-4,8H,(H,9,10);/q;+1/p-1
(3)InChIKey: ABBQHOQBGMUPJH-UHFFFAOYSA-M
Below are the toxicity information of this chemical:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| child | TDLo | multiple routes | 2970mg/kg/13D (2970mg/kg) | BEHAVIORAL: EXCITEMENT GASTROINTESTINAL: NAUSEA OR VOMITING | American Journal of Diseases of Children. Vol. 69, Pg. 37, 1945. |
| dog | LD50 | intravenous | 562mg/kg (562mg/kg) | BEHAVIORAL: ANALGESIA | Archives Internationales de Pharmacodynamie et de Therapie. Vol. 149, Pg. 571, 1964. |
| dog | LDLo | intraperitoneal | 990mg/kg (990mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. | |
| dog | LDLo | oral | 450mg/kg (450mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. | |
| dog | LDLo | subcutaneous | 200mg/kg (200mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES | Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. |
| frog | LDLo | subcutaneous | 250mg/kg (250mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. | |
| guinea pig | LDLo | intraperitoneal | 900mg/kg (900mg/kg) | "Abdernalden's Handbuch der Biologischen Arbeitsmethoden." Vol. 4, Pg. 1392, 1935. | |
| guinea pig | LDLo | subcutaneous | 800mg/kg (800mg/kg) | CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) BEHAVIORAL: EXCITEMENT LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Revue Medicale de la Suisse Romande. Vol. 15, Pg. 561, 1895. |
| human | LDLo | oral | 700mg/kg (700mg/kg) | BEHAVIORAL: EXCITEMENT BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA | New England Journal of Medicine. Vol. 232, Pg. 617, 1945. |
| mouse | LD50 | intramuscular | 760mg/kg (760mg/kg) | Acta Paediatrica Scandinavica. Vol. 59, Pg. 517, 1970. | |
| mouse | LD50 | intraperitoneal | 500mg/kg (500mg/kg) | Strahlentherapie. Vol. 127, Pg. 245, 1965. | |
| mouse | LD50 | intravenous | 500mg/kg (500mg/kg) | British Patent Document. Vol. #1009195, | |
| mouse | LD50 | oral | 540mg/kg (540mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 5, Pg. 572, 1955. | |
| mouse | LD50 | subcutaneous | 550mg/kg (550mg/kg) | Arzneimittel-Forschung. Drug Research. Vol. 8, Pg. 25, 1958. | |
| rabbit | LD50 | intravenous | 415mg/kg (415mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979. | |
| rabbit | LD50 | oral | 1700mg/kg (1700mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 89, Pg. 205, 1947. | |
| rat | LD50 | intraperitoneal | 542mg/kg (542mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 13, Pg. 791, 1979. | |
| rat | LD50 | oral | 930mg/kg (930mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD BEHAVIORAL: MUSCLE CONTRACTION OR SPASTICITY) | Science Reports of the Research Institutes, Tohoku University, Series C: Medicine. Vol. 36(1-4), Pg. 10, 1989. |
| women | TDLo | unreported | 1400mg/kg (1400mg/kg) | BEHAVIORAL: TOXIC PSYCHOSIS LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION SKIN AND APPENDAGES (SKIN): SWEATING: OTHER | JAMA, Journal of the American Medical Association. Vol. 126, Pg. 806, 1944. |

